Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Vanishing midbrain mass lesion - A germinoma?

Purkart TU, Seifert-Held T, Haybäck J, Holl E, Asslaber M, Payer F, Fazekas F.

J Neurol Sci. 2019 Sep 15;404:40-43. doi: 10.1016/j.jns.2019.06.013. Epub 2019 Jun 13. No abstract available.

PMID:
31325666
2.

Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.

Neuhauser M, Roetzer T, Oberndorfer S, Kitzwoegerer M, Payer F, Unterluggauer JJ, Haybaeck J, Stockhammer G, Iglseder S, Moser P, Thomé C, Stultschnig M, Wuertz F, Brandner-Kokalj T, Weis S, Bandke D, Pichler J, Hutterer M, Krenosz KJ, Boehm A, Mayrbaeurl B, Hager-Seifert A, Kaufmann H, Dumser M, Reiner-Concin A, Hoenigschnabl S, Kleindienst W, Hoffermann M, Dieckmann K, Kiesel B, Widhalm G, Marosi C, Jaeger U, Hainfellner A, Hackl M, Hainfellner JA, Preusser M, Woehrer A.

Acta Oncol. 2019 Jul;58(7):967-976. doi: 10.1080/0284186X.2019.1599137. Epub 2019 Apr 17.

PMID:
30994047
3.

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.

Klughammer J, Kiesel B, Roetzer T, Fortelny N, Nemc A, Nenning KH, Furtner J, Sheffield NC, Datlinger P, Peter N, Nowosielski M, Augustin M, Mischkulnig M, Ströbel T, Alpar D, Ergüner B, Senekowitsch M, Moser P, Freyschlag CF, Kerschbaumer J, Thomé C, Grams AE, Stockhammer G, Kitzwoegerer M, Oberndorfer S, Marhold F, Weis S, Trenkler J, Buchroithner J, Pichler J, Haybaeck J, Krassnig S, Mahdy Ali K, von Campe G, Payer F, Sherif C, Preiser J, Hauser T, Winkler PA, Kleindienst W, Würtz F, Brandner-Kokalj T, Stultschnig M, Schweiger S, Dieckmann K, Preusser M, Langs G, Baumann B, Knosp E, Widhalm G, Marosi C, Hainfellner JA, Woehrer A, Bock C.

Nat Med. 2018 Oct;24(10):1611-1624. doi: 10.1038/s41591-018-0156-x. Epub 2018 Aug 27.

4.

Symmetry of the arcuate fasciculus and its impact on language performance of patients with brain tumors in the language-dominant hemisphere.

Jehna M, Becker J, Zaar K, von Campe G, Mahdy Ali K, Reishofer G, Payer F, Synowitz M, Fazekas F, Enzinger C, Deutschmann H.

J Neurosurg. 2017 Dec;127(6):1407-1416. doi: 10.3171/2016.9.JNS161281. Epub 2017 Jan 27.

PMID:
28128689
5.

Poor short-term outcome in patients with ischaemic stroke and active cancer.

Kneihsl M, Enzinger C, Wünsch G, Khalil M, Culea V, Urbanic-Purkart T, Payer F, Niederkorn K, Fazekas F, Gattringer T.

J Neurol. 2016 Jan;263(1):150-6. doi: 10.1007/s00415-015-7954-6. Epub 2015 Nov 3.

PMID:
26530513
6.

Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.

Hoffermann M, Bruckmann L, Kariem Mahdy A, Asslaber M, Payer F, von Campe G.

Clin Neurol Neurosurg. 2015 Jan;128:60-9. doi: 10.1016/j.clineuro.2014.11.006. Epub 2014 Nov 15.

PMID:
25462098
7.

Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.

Woehrer A, Hackl M, Waldhör T, Weis S, Pichler J, Olschowski A, Buchroithner J, Maier H, Stockhammer G, Thomé C, Haybaeck J, Payer F, von Campe G, Kiefer A, Würtz F, Vince GH, Sedivy R, Oberndorfer S, Marhold F, Bordihn K, Stiglbauer W, Gruber-Mösenbacher U, Bauer R, Feichtinger J, Reiner-Concin A, Grisold W, Marosi C, Preusser M, Dieckmann K, Slavc I, Gatterbauer B, Widhalm G, Haberler C, Hainfellner JA; Austrian Brain Tumour Registry.

Br J Cancer. 2014 Jan 21;110(2):286-96. doi: 10.1038/bjc.2013.714. Epub 2013 Nov 19.

8.

Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.

Batchelor TT, Mulholland P, Neyns B, Nabors LB, Campone M, Wick A, Mason W, Mikkelsen T, Phuphanich S, Ashby LS, Degroot J, Gattamaneni R, Cher L, Rosenthal M, Payer F, Jürgensmeier JM, Jain RK, Sorensen AG, Xu J, Liu Q, van den Bent M.

J Clin Oncol. 2013 Sep 10;31(26):3212-8. doi: 10.1200/JCO.2012.47.2464. Epub 2013 Aug 12.

9.

Interdisciplinary treatment of glioblastoma: analysis of prognostic factors and treatment results in unselected patients.

Langsenlehner T, Groll MJ, Quehenberger F, Payer F, Mokry M, Kapp KS.

Neoplasma. 2012;59(6):662-8. doi: 10.4149/neo_2012_084.

PMID:
22862166
10.

NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH.

Eur J Cancer. 2012 Sep;48(14):2192-202. doi: 10.1016/j.ejca.2012.04.011. Epub 2012 May 18.

11.

[Pseudoprogression or pseudoresponse: a challenge for the diagnostic imaging in Glioblastoma multiforme].

Payer F.

Wien Med Wochenschr. 2011 Jan;161(1-2):13-9. doi: 10.1007/s10354-010-0860-8. Review. German.

PMID:
21312094
12.

Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodies.

Szkandera J, Ploner F, Bauernhofer T, Kasparek AK, Payer F, Balic M, Knechtel G, Gerger A, Gallè G, Samonigg H, Hofmann G.

Onkologie. 2010;33(8-9):452-4. doi: 10.1159/000317269. Epub 2010 Jul 6.

PMID:
20838061
13.

Herbal does not at all mean innocuous: the sixth case of hepatotoxicity associated with morinda citrifolia (noni).

Stadlbauer V, Weiss S, Payer F, Stauber RE.

Am J Gastroenterol. 2008 Sep;103(9):2406-7. doi: 10.1111/j.1572-0241.2008.02010_8.x. No abstract available.

PMID:
18844633
14.

Minimizing macrovessel signal in cerebral perfusion imaging using independent component analysis.

Reishofer G, Fazekas F, Keeling S, Enzinger C, Payer F, Simbrunner J, Stollberger R.

Magn Reson Med. 2007 Feb;57(2):278-88.

15.

Temozolomide for recurrent or progressive high-grade malignant glioma: results of an Austrian multicenter observational study.

Hassler M, Micksche M, Stockhammer G, Pichler J, Payer F, Abuja B, Deinsberger R, Marosi C.

Wien Klin Wochenschr. 2006 May;118(7-8):230-8.

PMID:
16794761
16.

Future aspects of the presurgical evaluation in epilepsy.

Feichtinger M, Holl A, Körner E, Schröttner O, Eder H, Unger F, Pendl G, Wurst L, Golaszewski S, Payer F, Fazekas F, Ott E.

Acta Neurochir Suppl. 2002;84:17-26. Review.

PMID:
12379001
17.

[F-18 fluorodeoxyglucose positron emission tomography in neurology].

Fazekas F, Payer F.

Wien Med Wochenschr. 2002;152(11-12):293-7. German.

PMID:
12138659
18.

Proximal Charcot-Marie-Tooth syndrome with duplication on chromosome 17p11.2.

Auer-Grumbach M, Wagner K, Payer F, Hartung HP.

Ann N Y Acad Sci. 1999 Sep 14;883:469-71. No abstract available.

PMID:
10586276
19.

Proximal Charcot-Marie-Tooth Syndrome with Duplication on Chromosome 17p11.2.

Auer-Grumbach M, Wagner K, Payer F, Hartung HP.

Ann N Y Acad Sci. 1999 Oct;883(1):469-471. doi: 10.1111/j.1749-6632.1999.tb08613.x. No abstract available.

PMID:
29086978
20.

Technetium-99m-ECD SPECT fails to show focal hyperemia of acute herpes encephalitis.

Fazekas F, Roob G, Payer F, Kapeller P, Strasser-Fuchs S, Aigner RM.

J Nucl Med. 1998 May;39(5):790-2.

21.

Language comprehension and regional cerebral defects in frontotemporal degeneration and Alzheimer's disease.

Grossman M, Payer F, Onishi K, D'Esposito M, Morrison D, Sadek A, Alavi A.

Neurology. 1998 Jan;50(1):157-63.

PMID:
9443473
22.

Constraints on the cerebral basis for semantic processing from neuroimaging studies of Alzheimer's disease.

Grossman M, Payer F, Onishi K, White-Devine T, Morrison D, D'Esposito M, Robinson K, Alavi A.

J Neurol Neurosurg Psychiatry. 1997 Aug;63(2):152-8.

23.

The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease.

Fazekas F, Kapeller P, Schmidt R, Offenbacher H, Payer F, Fazekas G.

J Neurol Sci. 1996 Oct;142(1-2):121-5.

PMID:
8902731
24.

Cerebral HMPAO SPECT in patients with major depression and healthy volunteers.

Mozley PD, Hornig-Rohan M, Woda AM, Kim HJ, Alavi A, Payer F, Amsterdam JD.

Prog Neuropsychopharmacol Biol Psychiatry. 1996 Apr;20(3):443-58.

PMID:
8771600
25.

Morphology-oriented analysis of cerebral SPET using matched magnetic resonance images.

Stollberger R, Fazekas F, Payer F, Flooh E.

Nucl Med Commun. 1995 Apr;16(4):265-72.

PMID:
7624107
26.

Single photon emission computed tomography in Alzheimer's disease and related disorders.

Newberg AB, Alavi A, Payer F.

Neuroimaging Clin N Am. 1995 Feb;5(1):103-23. Review.

PMID:
7743079
27.

Pathologic correlates of incidental MRI white matter signal hyperintensities.

Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H.

Neurology. 1993 Sep;43(9):1683-9.

PMID:
8414012
28.

Brain stem infarction and diaschisis. A SPECT cerebral perfusion study.

Fazekas F, Payer F, Valetitsch H, Schmidt R, Flooh E.

Stroke. 1993 Aug;24(8):1162-6.

PMID:
8342190
29.

Assessment of MRI criteria for a diagnosis of MS.

Offenbacher H, Fazekas F, Schmidt R, Freidl W, Flooh E, Payer F, Lechner H.

Neurology. 1993 May;43(5):905-9.

PMID:
8274173
30.

Brain magnetic resonance imaging in coronary artery bypass grafts: a pre- and postoperative assessment.

Schmidt R, Fazekas F, Offenbacher H, Mächler H, Freidl W, Payer F, Rigler B, Harrison MI, Lechner H.

Neurology. 1993 Apr;43(4):775-8.

PMID:
8469339
31.

Bilateral medial medullary infarction: magnetic resonance imaging and correlative histopathologic findings.

Kleinert G, Fazekas F, Kleinert R, Schmidt R, Payer F, Offenbacher H, Lechner H.

Eur Neurol. 1993;33(1):74-6.

PMID:
8440293
32.

Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers.

Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Payer F, Freidl W, Niederkorn K, Lechner H.

Arch Neurol. 1992 Aug;49(8):825-7.

PMID:
1524515
33.

The prevalence of cerebral damage varies with migraine type: a MRI study.

Fazekas F, Koch M, Schmidt R, Offenbacher H, Payer F, Freidl W, Lechner H.

Headache. 1992 Jun;32(6):287-91.

PMID:
1399549
34.

Superficial siderosis of the spinal cord: a rare cause of myelopathy diagnosed by MRI.

Offenbacher H, Fazekas F, Reisecker F, Schmidt R, Payer F, Lechner H.

Neurology. 1991 Dec;41(12):1987-9.

PMID:
1745361
35.

The morphologic correlate of incidental punctate white matter hyperintensities on MR images.

Fazekas F, Kleinert R, Offenbacher H, Payer F, Schmidt R, Kleinert G, Radner H, Lechner H.

AJNR Am J Neuroradiol. 1991 Sep-Oct;12(5):915-21.

PMID:
1950921
36.

MRI in tuberculous meningoencephalitis: report of four cases and review of the neuroimaging literature.

Offenbacher H, Fazekas F, Schmidt R, Kleinert R, Payer F, Kleinert G, Lechner H.

J Neurol. 1991 Sep;238(6):340-4. Review.

PMID:
1940987
37.

Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals.

Schmidt R, Fazekas F, Offenbacher H, Lytwyn H, Blematl B, Niederkorn K, Horner S, Payer F, Freidl W.

Arch Neurol. 1991 Apr;48(4):417-20.

PMID:
2012517
38.

Cerebral hemodynamic changes following treatment with erythropoietin.

Horina JH, Fazekas F, Niederkorn K, Payer F, Valetitsch H, Winkler HM, Horner S, Freidl W, Pogglitsch H, Krejs GJ.

Nephron. 1991;58(4):407-12.

PMID:
1922604

Supplemental Content

Support Center